Review



control scrambled shrna plasmid shctrl  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    OriGene control scrambled shrna plasmid shctrl
    Figure 3. Tet2 knockdown decreases myoblast differentiation. (A) Knockdown of Tet2 by using <t>shRNA.</t> Upper: C2C12 cells were transfected with Tet2-specific shRNA plasmid (shTet2) or a control shRNA plasmid <t>(shCtrl)</t> and then selected with puromycin. The mRNA levels of Tet family genes or myoblast differentiation- associated genes in puromycin-selected cells were detected by qRT-PCR. Lower: the cells were induced to differentiation and the mRNA levels of Tets or myoblast differentiation-associated genes were detected 4 d after differentiation induction. Myog, myogenin; MyoM, myomaker. (B) Western blot confirmation of Tet2 protein decline in shRNA- or siRNA-mediated Tet2 knockdown cells. β-actin was used as an internal control. The expected Tet2 band (NW: 224 kDa) is shown. Full-length blots are presented in Supplementary Figure S6. (C) Evaluation of myotube formation of Tet2 knockdown C2C12 cells. Myotubes were visualized by immunostaining for MyHC 6 d after differentiation induction (left). Nuclei were stained with DAPI. Scale bar, 100 μm. The fusion index was calculated as the ratio of the number of nuclei in MyHC-positive cells to the total number of nuclei present in the observation field. The quantitative analysis revealed a significant decrease in the fusion index of shTet2 C2C12 as compared with shCtrl cells (right). Data are presented as means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001.
    Control Scrambled Shrna Plasmid Shctrl, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 96 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+control+(shctrl)+vector/Scrambled+shRNA+control+in+pRFP-C-RS+shRNA+Vector/pm28272491-252-18-23
    Average 93 stars, based on 96 article reviews
    control scrambled shrna plasmid shctrl - by Bioz Stars, 2026-11
    93/100 stars

    Images

    1) Product Images from "Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro."

    Article Title: Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro.

    Journal: Scientific reports

    doi: 10.1038/srep43539

    Figure 3. Tet2 knockdown decreases myoblast differentiation. (A) Knockdown of Tet2 by using shRNA. Upper: C2C12 cells were transfected with Tet2-specific shRNA plasmid (shTet2) or a control shRNA plasmid (shCtrl) and then selected with puromycin. The mRNA levels of Tet family genes or myoblast differentiation- associated genes in puromycin-selected cells were detected by qRT-PCR. Lower: the cells were induced to differentiation and the mRNA levels of Tets or myoblast differentiation-associated genes were detected 4 d after differentiation induction. Myog, myogenin; MyoM, myomaker. (B) Western blot confirmation of Tet2 protein decline in shRNA- or siRNA-mediated Tet2 knockdown cells. β-actin was used as an internal control. The expected Tet2 band (NW: 224 kDa) is shown. Full-length blots are presented in Supplementary Figure S6. (C) Evaluation of myotube formation of Tet2 knockdown C2C12 cells. Myotubes were visualized by immunostaining for MyHC 6 d after differentiation induction (left). Nuclei were stained with DAPI. Scale bar, 100 μm. The fusion index was calculated as the ratio of the number of nuclei in MyHC-positive cells to the total number of nuclei present in the observation field. The quantitative analysis revealed a significant decrease in the fusion index of shTet2 C2C12 as compared with shCtrl cells (right). Data are presented as means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001.
    Figure Legend Snippet: Figure 3. Tet2 knockdown decreases myoblast differentiation. (A) Knockdown of Tet2 by using shRNA. Upper: C2C12 cells were transfected with Tet2-specific shRNA plasmid (shTet2) or a control shRNA plasmid (shCtrl) and then selected with puromycin. The mRNA levels of Tet family genes or myoblast differentiation- associated genes in puromycin-selected cells were detected by qRT-PCR. Lower: the cells were induced to differentiation and the mRNA levels of Tets or myoblast differentiation-associated genes were detected 4 d after differentiation induction. Myog, myogenin; MyoM, myomaker. (B) Western blot confirmation of Tet2 protein decline in shRNA- or siRNA-mediated Tet2 knockdown cells. β-actin was used as an internal control. The expected Tet2 band (NW: 224 kDa) is shown. Full-length blots are presented in Supplementary Figure S6. (C) Evaluation of myotube formation of Tet2 knockdown C2C12 cells. Myotubes were visualized by immunostaining for MyHC 6 d after differentiation induction (left). Nuclei were stained with DAPI. Scale bar, 100 μm. The fusion index was calculated as the ratio of the number of nuclei in MyHC-positive cells to the total number of nuclei present in the observation field. The quantitative analysis revealed a significant decrease in the fusion index of shTet2 C2C12 as compared with shCtrl cells (right). Data are presented as means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001.

    Techniques Used: Knockdown, shRNA, Transfection, Plasmid Preparation, Control, Quantitative RT-PCR, Western Blot, Immunostaining, Staining

    Figure 4. Promoter methylation status of myoblast differentiation-associated genes in Tet2 knockdown C2C12. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were cultured in growth medium. Methylation status of promoters of myogenin (A), Myf6 (B) or myomaker (C) was analyzed by using bisulfite sequencing. Numbers with a minus sign indicate the position of CpG relative to the transcription starting site. Each row represents an individual clone sequenced; black and white circles represent methylated and unmethylated CpGs, respectively. Percentage of methylation indicates the proportion of methylated CpG sites relative to the whole CpG sites examined.
    Figure Legend Snippet: Figure 4. Promoter methylation status of myoblast differentiation-associated genes in Tet2 knockdown C2C12. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were cultured in growth medium. Methylation status of promoters of myogenin (A), Myf6 (B) or myomaker (C) was analyzed by using bisulfite sequencing. Numbers with a minus sign indicate the position of CpG relative to the transcription starting site. Each row represents an individual clone sequenced; black and white circles represent methylated and unmethylated CpGs, respectively. Percentage of methylation indicates the proportion of methylated CpG sites relative to the whole CpG sites examined.

    Techniques Used: Methylation, Knockdown, Transfection, shRNA, Control, Cell Culture, Methylation Sequencing

    Figure 5. Knockdown of Tet2 decreases the ability of vitamin C to enhance 5hmC formation and to promote the expression of myoblast differentiation-associated genes. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were cultured in growth medium with or without vitamin C (VC; 500 μM). (A) Immunostaining for 5hmC in shTet2 vs shCtrl C2C12 cells with or without VC treatment. Nuclei were stained with DAPI. Scale bar, 50 μm. (B) Quantification of fluorescence intensities of 5hmC. The quantitative analysis revealed that Tet2 knockdown decreased the ability of VC to enhance 5hmC formation. (C) qRT-PCR analysis for the expression of myogenin, Myf6 and myomaker in shTet2 vs shCtrl C2C12 cells with or without VC treatment. Gapdh was used as an internal control. Data are presented as means ± SEM (n = 3). Asterisks above columns represent significant difference among groups (p < 0.05).
    Figure Legend Snippet: Figure 5. Knockdown of Tet2 decreases the ability of vitamin C to enhance 5hmC formation and to promote the expression of myoblast differentiation-associated genes. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were cultured in growth medium with or without vitamin C (VC; 500 μM). (A) Immunostaining for 5hmC in shTet2 vs shCtrl C2C12 cells with or without VC treatment. Nuclei were stained with DAPI. Scale bar, 50 μm. (B) Quantification of fluorescence intensities of 5hmC. The quantitative analysis revealed that Tet2 knockdown decreased the ability of VC to enhance 5hmC formation. (C) qRT-PCR analysis for the expression of myogenin, Myf6 and myomaker in shTet2 vs shCtrl C2C12 cells with or without VC treatment. Gapdh was used as an internal control. Data are presented as means ± SEM (n = 3). Asterisks above columns represent significant difference among groups (p < 0.05).

    Techniques Used: Knockdown, Expressing, Transfection, shRNA, Control, Cell Culture, Immunostaining, Staining, Fluorescence, Quantitative RT-PCR

    Figure 6. Knockdown of Tet2 decreases the ability of vitamin C to promote myoblast differentiation. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were subdivided into two experimental groups: non-vitamin C treatment group (indicated as VC−), in which VC was absent in both growth medium and differentiation medium, and VC-treatment group (indicated as VC+), in which the cells were first cultured for 48 h in growth medium containing 500 μM VC, and then were shifted to differentiated medium containing 500 μM VC. (A) Evaluation of myoblast differentiation in different treatment groups. Cells after 6 d of differentiation induction were immunostained with anti-MyHC antibodies to mark the myotubes. Nuclei were stained with DAPI. Scale bar, 100 μm. (B) Quantification analysis for differentiation efficiency in different treatment groups. The fusion index was calculated as the ratio of the number of nuclei in MyHC- positive cells to the total number of nuclei present in the observation field. (C) qRT-PCR analysis for the expression of myogenin, Myf6 and myomaker in C2C12 cells after 4 d of differentiation induction in different treatment groups. Gapdh was used as an internal control. Data are presented as means ± SEM (n = 3). Asterisks above columns represent significant difference among groups (p < 0.05).
    Figure Legend Snippet: Figure 6. Knockdown of Tet2 decreases the ability of vitamin C to promote myoblast differentiation. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were subdivided into two experimental groups: non-vitamin C treatment group (indicated as VC−), in which VC was absent in both growth medium and differentiation medium, and VC-treatment group (indicated as VC+), in which the cells were first cultured for 48 h in growth medium containing 500 μM VC, and then were shifted to differentiated medium containing 500 μM VC. (A) Evaluation of myoblast differentiation in different treatment groups. Cells after 6 d of differentiation induction were immunostained with anti-MyHC antibodies to mark the myotubes. Nuclei were stained with DAPI. Scale bar, 100 μm. (B) Quantification analysis for differentiation efficiency in different treatment groups. The fusion index was calculated as the ratio of the number of nuclei in MyHC- positive cells to the total number of nuclei present in the observation field. (C) qRT-PCR analysis for the expression of myogenin, Myf6 and myomaker in C2C12 cells after 4 d of differentiation induction in different treatment groups. Gapdh was used as an internal control. Data are presented as means ± SEM (n = 3). Asterisks above columns represent significant difference among groups (p < 0.05).

    Techniques Used: Knockdown, Transfection, shRNA, Control, Cell Culture, Staining, Quantitative RT-PCR, Expressing

    Related Articles

    shRNA:

    Article Title: Occludin Is Essential to Maintain Normal Alveolar Barrier Integrity and Its Protective Role During ARDS Progression
    Article Snippet: The plasmid pcDNA3.1 was from Invitrogen/Thermofisher (Carlsbad, CA, USA, catalog #V79020). pCMV-occludin expresses a GFP-tagged mouse occludin from the CMV promoter (Origene, Rockville, MD, USA, catalog # MG226013). pEGFP-C1 expresses GFP from the CMV promoter (Clontech, Mountain View, CA, USA, catalog # 6084-1). .. Four distinct RFP-expressing occludin shRNA plasmids (catalog # TF501526) and a scrambled shRNA plasmid (catalog # TR30015) were purchased from Origene (Rockville, MD, USA). ..

    Article Title: Clathrin mediates membrane fission and budding by constricting membrane pores.
    Article Snippet: For knockdown of endogenous CHC in bovine chromaffin cells, three siRNA duplexes for bovine CHC (5′- CCAGAUUGUCGAUGUGUUU-3′, 5′-GCAUCUACAUGAAUAGAAU-3′, and 5′-CUAUGACAGUCGUGUUGUU-3′) labeled with Cyanine 3 and scrambled control siRNA (SIC003) were purchased from Sigma-Aldrich. .. A mixture of these three siRNAs was used for experiments. shRNA plasmids for bovine CHC (5′- CGGTTGCTCTTGTTACGGATAATGCAGTT-3′) and scrambled control (TR30015) tagged with RFP were purchased from Origene. .. The C1573S CHC mutant was generated from pEGFP-C1-CHC17(Addgene# 59799) plasmid.

    Article Title: Depleting trafficking regulator CASK promotes intercalated disc organization and ventricular function
    Article Snippet: .. shRNA sequences for CASK 5’-tggagaatgtgaccagagttcgcctggta-3’ (shCASK) and control (shscr) 5’-gcactaccagagctaactcagatagtact-3’ were provided by Origen into a pRFP-C-RS vector. shCASK or shscr under a U6 promoter were subcloned into pShuttle vector containing an IRES-GFP reporter and produced in adenovirus (CPV, UMR1089, Nantes). ..

    Article Title: Rudhira-mediated microtubule stability controls TGFβ signaling during mouse vascular development
    Article Snippet: .. In brief, rudhira shRNA vectors (715, 716) and scrambled (NS) control vector (TR30015) (Origene, USA) were microporated into SVEC (mouse EC line) and selected for stable line generation. ..

    Article Title: A PACAP-activated network for secretion requires coordination of Ca<sup>2+</sup> influx and Ca<sup>2+</sup> mobilization
    Article Snippet: .. The scrambled shRNA and IP3R1 shRNA plasmids were purchased from OriGene; the 29mer sequence of scrambled shRNA (Catalogue# TR30015) is 5′-GCACTACCAGAGCTAACTCAGATAGTACT-3′, the 29mer sequence of IP3R1 (also called Itpr1) shRNA (Catalogue# TF517036) is 5′-TCAGCACCTTAGGCTTGGTTG-ATGACCGT-3′, and the transfected cells were identified based on their red fluorescence encoded by shRNA vectors. .. For transfections, cell pellets were resuspended in 110 μl of sucrose-based buffer (250 mM sucrose and 1 mM MgCl2 in DPBS [Life Technologies, Catalogue# 10010-023]).

    Article Title: Regulation of cannabinoid and opioid receptor levels by endogenous and pharmacological chaperones .
    Article Snippet: 1 Regulation of cannabinoid and opioid receptor levels by endogenous and pharmacological chaperones Achla Gupta1, Ivone Gomes1, Aya Osman1, Wakako Fujita2, and Lakshmi A. Devi1@ @Corresponding author: lakshmi.devi@mssm.edu 1Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.. 2Current address: Faculty of Pharmacy, Juntendo University, Urayasu, Chiba, Japan Footnote: Funding was from the National Institute of Drug Abuse [DA008863, DA058681] and National Center for Advancing Translational Sciences [R03 TR002940] grants (to LAD), NARSAD Young Investigator award Grant #31297 (to AO), and JSPS KAKENHI [21K07275] grant (to WF).. Conflict-of-interest statement: No author has an actual or perceived conflict of interest with the contents of this article at A SPE T Journals on A ugust 21, 2024 jpet.aspetjournals.org D ow nloaded from 2 Running Title: Regulation of expression of CB1R-DOR @ Corresponding Author: lakshmi.devi@mssm.edu No. of text pages: 33

    Article Title: Role of the Two-Pore-Domain Potassium channel TREK-1 (K 2P 2.1) in Hyperoxia- and Mechanical Stretch-Induced Alveolar Epithelial Injury
    Article Snippet: .. Briefly, for stable TREK-1 knockdown, human AT2 (A549) cells were transfected with anti-TREK-1 shRNA using a commercially available pRFP-C-RS vector (Origene, catalog #TR30015) using the TurboFectin 8.0-based transfection system. ..

    Plasmid Preparation:

    Article Title: Occludin Is Essential to Maintain Normal Alveolar Barrier Integrity and Its Protective Role During ARDS Progression
    Article Snippet: The plasmid pcDNA3.1 was from Invitrogen/Thermofisher (Carlsbad, CA, USA, catalog #V79020). pCMV-occludin expresses a GFP-tagged mouse occludin from the CMV promoter (Origene, Rockville, MD, USA, catalog # MG226013). pEGFP-C1 expresses GFP from the CMV promoter (Clontech, Mountain View, CA, USA, catalog # 6084-1). .. Four distinct RFP-expressing occludin shRNA plasmids (catalog # TF501526) and a scrambled shRNA plasmid (catalog # TR30015) were purchased from Origene (Rockville, MD, USA). ..

    Article Title: Depleting trafficking regulator CASK promotes intercalated disc organization and ventricular function
    Article Snippet: .. shRNA sequences for CASK 5’-tggagaatgtgaccagagttcgcctggta-3’ (shCASK) and control (shscr) 5’-gcactaccagagctaactcagatagtact-3’ were provided by Origen into a pRFP-C-RS vector. shCASK or shscr under a U6 promoter were subcloned into pShuttle vector containing an IRES-GFP reporter and produced in adenovirus (CPV, UMR1089, Nantes). ..

    Article Title: Rudhira-mediated microtubule stability controls TGFβ signaling during mouse vascular development
    Article Snippet: .. In brief, rudhira shRNA vectors (715, 716) and scrambled (NS) control vector (TR30015) (Origene, USA) were microporated into SVEC (mouse EC line) and selected for stable line generation. ..

    Control:

    Article Title: Clathrin mediates membrane fission and budding by constricting membrane pores.
    Article Snippet: For knockdown of endogenous CHC in bovine chromaffin cells, three siRNA duplexes for bovine CHC (5′- CCAGAUUGUCGAUGUGUUU-3′, 5′-GCAUCUACAUGAAUAGAAU-3′, and 5′-CUAUGACAGUCGUGUUGUU-3′) labeled with Cyanine 3 and scrambled control siRNA (SIC003) were purchased from Sigma-Aldrich. .. A mixture of these three siRNAs was used for experiments. shRNA plasmids for bovine CHC (5′- CGGTTGCTCTTGTTACGGATAATGCAGTT-3′) and scrambled control (TR30015) tagged with RFP were purchased from Origene. .. The C1573S CHC mutant was generated from pEGFP-C1-CHC17(Addgene# 59799) plasmid.

    Article Title: Depleting trafficking regulator CASK promotes intercalated disc organization and ventricular function
    Article Snippet: .. shRNA sequences for CASK 5’-tggagaatgtgaccagagttcgcctggta-3’ (shCASK) and control (shscr) 5’-gcactaccagagctaactcagatagtact-3’ were provided by Origen into a pRFP-C-RS vector. shCASK or shscr under a U6 promoter were subcloned into pShuttle vector containing an IRES-GFP reporter and produced in adenovirus (CPV, UMR1089, Nantes). ..

    Article Title: Rudhira-mediated microtubule stability controls TGFβ signaling during mouse vascular development
    Article Snippet: .. In brief, rudhira shRNA vectors (715, 716) and scrambled (NS) control vector (TR30015) (Origene, USA) were microporated into SVEC (mouse EC line) and selected for stable line generation. ..

    Article Title: Regulation of cannabinoid and opioid receptor levels by endogenous and pharmacological chaperones .
    Article Snippet: 1 Regulation of cannabinoid and opioid receptor levels by endogenous and pharmacological chaperones Achla Gupta1, Ivone Gomes1, Aya Osman1, Wakako Fujita2, and Lakshmi A. Devi1@ @Corresponding author: lakshmi.devi@mssm.edu 1Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.. 2Current address: Faculty of Pharmacy, Juntendo University, Urayasu, Chiba, Japan Footnote: Funding was from the National Institute of Drug Abuse [DA008863, DA058681] and National Center for Advancing Translational Sciences [R03 TR002940] grants (to LAD), NARSAD Young Investigator award Grant #31297 (to AO), and JSPS KAKENHI [21K07275] grant (to WF).. Conflict-of-interest statement: No author has an actual or perceived conflict of interest with the contents of this article at A SPE T Journals on A ugust 21, 2024 jpet.aspetjournals.org D ow nloaded from 2 Running Title: Regulation of expression of CB1R-DOR @ Corresponding Author: lakshmi.devi@mssm.edu No. of text pages: 33

    Produced:

    Article Title: Depleting trafficking regulator CASK promotes intercalated disc organization and ventricular function
    Article Snippet: .. shRNA sequences for CASK 5’-tggagaatgtgaccagagttcgcctggta-3’ (shCASK) and control (shscr) 5’-gcactaccagagctaactcagatagtact-3’ were provided by Origen into a pRFP-C-RS vector. shCASK or shscr under a U6 promoter were subcloned into pShuttle vector containing an IRES-GFP reporter and produced in adenovirus (CPV, UMR1089, Nantes). ..

    Negative Control:

    Article Title: Tenascin-C expression in relation to tumor-stroma interaction in ameloblastoma.
    Article Snippet: RNA interference Protein knockdown was carried out using small interfering RNA (siRNA) oligonucleotides, si TNC (siRNA for TNC) was purchased from OriGene Technologies (Rockville, MD, USA). .. For negative control, Scramble siRNA (siNeg) was purchased from OriGene. .. siRNA was transfected into AM-1 cells at 25pmol/250μL final concentrations with ScreenFect siRNA (Fujifilm Wako), using a reverse transfection method according to the manufacture’s protocols.

    Sequencing:

    Article Title: A PACAP-activated network for secretion requires coordination of Ca<sup>2+</sup> influx and Ca<sup>2+</sup> mobilization
    Article Snippet: .. The scrambled shRNA and IP3R1 shRNA plasmids were purchased from OriGene; the 29mer sequence of scrambled shRNA (Catalogue# TR30015) is 5′-GCACTACCAGAGCTAACTCAGATAGTACT-3′, the 29mer sequence of IP3R1 (also called Itpr1) shRNA (Catalogue# TF517036) is 5′-TCAGCACCTTAGGCTTGGTTG-ATGACCGT-3′, and the transfected cells were identified based on their red fluorescence encoded by shRNA vectors. .. For transfections, cell pellets were resuspended in 110 μl of sucrose-based buffer (250 mM sucrose and 1 mM MgCl2 in DPBS [Life Technologies, Catalogue# 10010-023]).

    Transfection:

    Article Title: A PACAP-activated network for secretion requires coordination of Ca<sup>2+</sup> influx and Ca<sup>2+</sup> mobilization
    Article Snippet: .. The scrambled shRNA and IP3R1 shRNA plasmids were purchased from OriGene; the 29mer sequence of scrambled shRNA (Catalogue# TR30015) is 5′-GCACTACCAGAGCTAACTCAGATAGTACT-3′, the 29mer sequence of IP3R1 (also called Itpr1) shRNA (Catalogue# TF517036) is 5′-TCAGCACCTTAGGCTTGGTTG-ATGACCGT-3′, and the transfected cells were identified based on their red fluorescence encoded by shRNA vectors. .. For transfections, cell pellets were resuspended in 110 μl of sucrose-based buffer (250 mM sucrose and 1 mM MgCl2 in DPBS [Life Technologies, Catalogue# 10010-023]).

    Article Title: Role of the Two-Pore-Domain Potassium channel TREK-1 (K 2P 2.1) in Hyperoxia- and Mechanical Stretch-Induced Alveolar Epithelial Injury
    Article Snippet: .. Briefly, for stable TREK-1 knockdown, human AT2 (A549) cells were transfected with anti-TREK-1 shRNA using a commercially available pRFP-C-RS vector (Origene, catalog #TR30015) using the TurboFectin 8.0-based transfection system. ..

    Fluorescence:

    Article Title: A PACAP-activated network for secretion requires coordination of Ca<sup>2+</sup> influx and Ca<sup>2+</sup> mobilization
    Article Snippet: .. The scrambled shRNA and IP3R1 shRNA plasmids were purchased from OriGene; the 29mer sequence of scrambled shRNA (Catalogue# TR30015) is 5′-GCACTACCAGAGCTAACTCAGATAGTACT-3′, the 29mer sequence of IP3R1 (also called Itpr1) shRNA (Catalogue# TF517036) is 5′-TCAGCACCTTAGGCTTGGTTG-ATGACCGT-3′, and the transfected cells were identified based on their red fluorescence encoded by shRNA vectors. .. For transfections, cell pellets were resuspended in 110 μl of sucrose-based buffer (250 mM sucrose and 1 mM MgCl2 in DPBS [Life Technologies, Catalogue# 10010-023]).

    Knockdown:

    Article Title: Role of the Two-Pore-Domain Potassium channel TREK-1 (K 2P 2.1) in Hyperoxia- and Mechanical Stretch-Induced Alveolar Epithelial Injury
    Article Snippet: .. Briefly, for stable TREK-1 knockdown, human AT2 (A549) cells were transfected with anti-TREK-1 shRNA using a commercially available pRFP-C-RS vector (Origene, catalog #TR30015) using the TurboFectin 8.0-based transfection system. ..



    Similar Products

    96
    Addgene inc lentiviral vector plko 1 shrna control shctrl
    Lentiviral Vector Plko 1 Shrna Control Shctrl, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+control+(shctrl)+vector/pLKO%2E1+-+TRC+control+(Plasmid+%2310879)/pm41596422-229-0-6
    Average 96 stars, based on 1 article reviews
    lentiviral vector plko 1 shrna control shctrl - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    90
    Shanghai Genechem Ltd retroviral vectors containing short hairpin rnas (shrnas) targeting mif and a shrna control (shctrl)
    Retroviral Vectors Containing Short Hairpin Rnas (Shrnas) Targeting Mif And A Shrna Control (Shctrl), supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+control+(shctrl)+vector/retroviral+vectors+containing+short+hairpin+rnas++shrnas++targeting+mif+and+a+shrna+control++shctrl+/10__3892_slash_ol__2025__14910-143-10-35
    Average 90 stars, based on 1 article reviews
    retroviral vectors containing short hairpin rnas (shrnas) targeting mif and a shrna control (shctrl) - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    86
    Genechem control shrna vector shctrl
    Control Shrna Vector Shctrl, supplied by Genechem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+control+(shctrl)+vector/control+shrna+vector++shctrl+/pm39218837-51-27-31
    Average 86 stars, based on 1 article reviews
    control shrna vector shctrl - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    96
    OriGene shctrl constructs
    Shctrl Constructs, supplied by OriGene, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+control+(shctrl)+vector/Scrambled+shRNA+control+in+pGFP-C-shLenti+shRNA+Vector/pm38873940-270-3-8
    Average 96 stars, based on 1 article reviews
    shctrl constructs - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    90
    Genechem shrna control (shctrl) vector
    Shrna Control (Shctrl) Vector, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+control+(shctrl)+vector/shctrl/pmc07841132-33-9-17
    Average 90 stars, based on 1 article reviews
    shrna control (shctrl) vector - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    96
    Addgene inc lentiviral vector shrna control shctrl
    Lentiviral Vector Shrna Control Shctrl, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+control+(shctrl)+vector/scramble+shRNA+(Plasmid+%231864)/pmc09283934-178-0-6
    Average 96 stars, based on 1 article reviews
    lentiviral vector shrna control shctrl - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    OriGene gtacatctctagcagtgctggagccaggt origene tl309181c pgfp c shlenti scramble shctrl
    Gtacatctctagcagtgctggagccaggt Origene Tl309181c Pgfp C Shlenti Scramble Shctrl, supplied by OriGene, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+control+(shctrl)+vector/Scrambled+shRNA+control+in+pGFP-C-shLenti+shRNA+Vector/pmc06538630__41467_2019_10275_MOESM1_ESM-55-80-81
    Average 96 stars, based on 1 article reviews
    gtacatctctagcagtgctggagccaggt origene tl309181c pgfp c shlenti scramble shctrl - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    93
    OriGene control scrambled shrna plasmid shctrl
    Figure 3. Tet2 knockdown decreases myoblast differentiation. (A) Knockdown of Tet2 by using <t>shRNA.</t> Upper: C2C12 cells were transfected with Tet2-specific shRNA plasmid (shTet2) or a control shRNA plasmid <t>(shCtrl)</t> and then selected with puromycin. The mRNA levels of Tet family genes or myoblast differentiation- associated genes in puromycin-selected cells were detected by qRT-PCR. Lower: the cells were induced to differentiation and the mRNA levels of Tets or myoblast differentiation-associated genes were detected 4 d after differentiation induction. Myog, myogenin; MyoM, myomaker. (B) Western blot confirmation of Tet2 protein decline in shRNA- or siRNA-mediated Tet2 knockdown cells. β-actin was used as an internal control. The expected Tet2 band (NW: 224 kDa) is shown. Full-length blots are presented in Supplementary Figure S6. (C) Evaluation of myotube formation of Tet2 knockdown C2C12 cells. Myotubes were visualized by immunostaining for MyHC 6 d after differentiation induction (left). Nuclei were stained with DAPI. Scale bar, 100 μm. The fusion index was calculated as the ratio of the number of nuclei in MyHC-positive cells to the total number of nuclei present in the observation field. The quantitative analysis revealed a significant decrease in the fusion index of shTet2 C2C12 as compared with shCtrl cells (right). Data are presented as means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001.
    Control Scrambled Shrna Plasmid Shctrl, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+control+(shctrl)+vector/Scrambled+shRNA+control+in+pRFP-C-RS+shRNA+Vector/pm28272491-252-18-23
    Average 93 stars, based on 1 article reviews
    control scrambled shrna plasmid shctrl - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    96
    OriGene shctrl
    Figure 3. Tet2 knockdown decreases myoblast differentiation. (A) Knockdown of Tet2 by using <t>shRNA.</t> Upper: C2C12 cells were transfected with Tet2-specific shRNA plasmid (shTet2) or a control shRNA plasmid <t>(shCtrl)</t> and then selected with puromycin. The mRNA levels of Tet family genes or myoblast differentiation- associated genes in puromycin-selected cells were detected by qRT-PCR. Lower: the cells were induced to differentiation and the mRNA levels of Tets or myoblast differentiation-associated genes were detected 4 d after differentiation induction. Myog, myogenin; MyoM, myomaker. (B) Western blot confirmation of Tet2 protein decline in shRNA- or siRNA-mediated Tet2 knockdown cells. β-actin was used as an internal control. The expected Tet2 band (NW: 224 kDa) is shown. Full-length blots are presented in Supplementary Figure S6. (C) Evaluation of myotube formation of Tet2 knockdown C2C12 cells. Myotubes were visualized by immunostaining for MyHC 6 d after differentiation induction (left). Nuclei were stained with DAPI. Scale bar, 100 μm. The fusion index was calculated as the ratio of the number of nuclei in MyHC-positive cells to the total number of nuclei present in the observation field. The quantitative analysis revealed a significant decrease in the fusion index of shTet2 C2C12 as compared with shCtrl cells (right). Data are presented as means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001.
    Shctrl, supplied by OriGene, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+control+(shctrl)+vector/Scrambled+shRNA+control+in+pGFP-C-shLenti+shRNA+Vector/pmc05861082-196-21-33
    Average 96 stars, based on 1 article reviews
    shctrl - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Figure 3. Tet2 knockdown decreases myoblast differentiation. (A) Knockdown of Tet2 by using shRNA. Upper: C2C12 cells were transfected with Tet2-specific shRNA plasmid (shTet2) or a control shRNA plasmid (shCtrl) and then selected with puromycin. The mRNA levels of Tet family genes or myoblast differentiation- associated genes in puromycin-selected cells were detected by qRT-PCR. Lower: the cells were induced to differentiation and the mRNA levels of Tets or myoblast differentiation-associated genes were detected 4 d after differentiation induction. Myog, myogenin; MyoM, myomaker. (B) Western blot confirmation of Tet2 protein decline in shRNA- or siRNA-mediated Tet2 knockdown cells. β-actin was used as an internal control. The expected Tet2 band (NW: 224 kDa) is shown. Full-length blots are presented in Supplementary Figure S6. (C) Evaluation of myotube formation of Tet2 knockdown C2C12 cells. Myotubes were visualized by immunostaining for MyHC 6 d after differentiation induction (left). Nuclei were stained with DAPI. Scale bar, 100 μm. The fusion index was calculated as the ratio of the number of nuclei in MyHC-positive cells to the total number of nuclei present in the observation field. The quantitative analysis revealed a significant decrease in the fusion index of shTet2 C2C12 as compared with shCtrl cells (right). Data are presented as means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001.

    Journal: Scientific reports

    Article Title: Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro.

    doi: 10.1038/srep43539

    Figure Lengend Snippet: Figure 3. Tet2 knockdown decreases myoblast differentiation. (A) Knockdown of Tet2 by using shRNA. Upper: C2C12 cells were transfected with Tet2-specific shRNA plasmid (shTet2) or a control shRNA plasmid (shCtrl) and then selected with puromycin. The mRNA levels of Tet family genes or myoblast differentiation- associated genes in puromycin-selected cells were detected by qRT-PCR. Lower: the cells were induced to differentiation and the mRNA levels of Tets or myoblast differentiation-associated genes were detected 4 d after differentiation induction. Myog, myogenin; MyoM, myomaker. (B) Western blot confirmation of Tet2 protein decline in shRNA- or siRNA-mediated Tet2 knockdown cells. β-actin was used as an internal control. The expected Tet2 band (NW: 224 kDa) is shown. Full-length blots are presented in Supplementary Figure S6. (C) Evaluation of myotube formation of Tet2 knockdown C2C12 cells. Myotubes were visualized by immunostaining for MyHC 6 d after differentiation induction (left). Nuclei were stained with DAPI. Scale bar, 100 μm. The fusion index was calculated as the ratio of the number of nuclei in MyHC-positive cells to the total number of nuclei present in the observation field. The quantitative analysis revealed a significant decrease in the fusion index of shTet2 C2C12 as compared with shCtrl cells (right). Data are presented as means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001.

    Article Snippet: To achieve persistent knockdown of Tet2, C2C12 cells was transfected with a Tet2 shRNA plasmid (shTet2) or a control scrambled shRNA plasmid (shCtrl) (Origene Technologies).

    Techniques: Knockdown, shRNA, Transfection, Plasmid Preparation, Control, Quantitative RT-PCR, Western Blot, Immunostaining, Staining

    Figure 4. Promoter methylation status of myoblast differentiation-associated genes in Tet2 knockdown C2C12. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were cultured in growth medium. Methylation status of promoters of myogenin (A), Myf6 (B) or myomaker (C) was analyzed by using bisulfite sequencing. Numbers with a minus sign indicate the position of CpG relative to the transcription starting site. Each row represents an individual clone sequenced; black and white circles represent methylated and unmethylated CpGs, respectively. Percentage of methylation indicates the proportion of methylated CpG sites relative to the whole CpG sites examined.

    Journal: Scientific reports

    Article Title: Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro.

    doi: 10.1038/srep43539

    Figure Lengend Snippet: Figure 4. Promoter methylation status of myoblast differentiation-associated genes in Tet2 knockdown C2C12. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were cultured in growth medium. Methylation status of promoters of myogenin (A), Myf6 (B) or myomaker (C) was analyzed by using bisulfite sequencing. Numbers with a minus sign indicate the position of CpG relative to the transcription starting site. Each row represents an individual clone sequenced; black and white circles represent methylated and unmethylated CpGs, respectively. Percentage of methylation indicates the proportion of methylated CpG sites relative to the whole CpG sites examined.

    Article Snippet: To achieve persistent knockdown of Tet2, C2C12 cells was transfected with a Tet2 shRNA plasmid (shTet2) or a control scrambled shRNA plasmid (shCtrl) (Origene Technologies).

    Techniques: Methylation, Knockdown, Transfection, shRNA, Control, Cell Culture, Methylation Sequencing

    Figure 5. Knockdown of Tet2 decreases the ability of vitamin C to enhance 5hmC formation and to promote the expression of myoblast differentiation-associated genes. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were cultured in growth medium with or without vitamin C (VC; 500 μM). (A) Immunostaining for 5hmC in shTet2 vs shCtrl C2C12 cells with or without VC treatment. Nuclei were stained with DAPI. Scale bar, 50 μm. (B) Quantification of fluorescence intensities of 5hmC. The quantitative analysis revealed that Tet2 knockdown decreased the ability of VC to enhance 5hmC formation. (C) qRT-PCR analysis for the expression of myogenin, Myf6 and myomaker in shTet2 vs shCtrl C2C12 cells with or without VC treatment. Gapdh was used as an internal control. Data are presented as means ± SEM (n = 3). Asterisks above columns represent significant difference among groups (p < 0.05).

    Journal: Scientific reports

    Article Title: Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro.

    doi: 10.1038/srep43539

    Figure Lengend Snippet: Figure 5. Knockdown of Tet2 decreases the ability of vitamin C to enhance 5hmC formation and to promote the expression of myoblast differentiation-associated genes. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were cultured in growth medium with or without vitamin C (VC; 500 μM). (A) Immunostaining for 5hmC in shTet2 vs shCtrl C2C12 cells with or without VC treatment. Nuclei were stained with DAPI. Scale bar, 50 μm. (B) Quantification of fluorescence intensities of 5hmC. The quantitative analysis revealed that Tet2 knockdown decreased the ability of VC to enhance 5hmC formation. (C) qRT-PCR analysis for the expression of myogenin, Myf6 and myomaker in shTet2 vs shCtrl C2C12 cells with or without VC treatment. Gapdh was used as an internal control. Data are presented as means ± SEM (n = 3). Asterisks above columns represent significant difference among groups (p < 0.05).

    Article Snippet: To achieve persistent knockdown of Tet2, C2C12 cells was transfected with a Tet2 shRNA plasmid (shTet2) or a control scrambled shRNA plasmid (shCtrl) (Origene Technologies).

    Techniques: Knockdown, Expressing, Transfection, shRNA, Control, Cell Culture, Immunostaining, Staining, Fluorescence, Quantitative RT-PCR

    Figure 6. Knockdown of Tet2 decreases the ability of vitamin C to promote myoblast differentiation. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were subdivided into two experimental groups: non-vitamin C treatment group (indicated as VC−), in which VC was absent in both growth medium and differentiation medium, and VC-treatment group (indicated as VC+), in which the cells were first cultured for 48 h in growth medium containing 500 μM VC, and then were shifted to differentiated medium containing 500 μM VC. (A) Evaluation of myoblast differentiation in different treatment groups. Cells after 6 d of differentiation induction were immunostained with anti-MyHC antibodies to mark the myotubes. Nuclei were stained with DAPI. Scale bar, 100 μm. (B) Quantification analysis for differentiation efficiency in different treatment groups. The fusion index was calculated as the ratio of the number of nuclei in MyHC- positive cells to the total number of nuclei present in the observation field. (C) qRT-PCR analysis for the expression of myogenin, Myf6 and myomaker in C2C12 cells after 4 d of differentiation induction in different treatment groups. Gapdh was used as an internal control. Data are presented as means ± SEM (n = 3). Asterisks above columns represent significant difference among groups (p < 0.05).

    Journal: Scientific reports

    Article Title: Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro.

    doi: 10.1038/srep43539

    Figure Lengend Snippet: Figure 6. Knockdown of Tet2 decreases the ability of vitamin C to promote myoblast differentiation. C2C12 cells transfected with Tet2 shRNA (shTet2) or control shRNA (shCtrl) were subdivided into two experimental groups: non-vitamin C treatment group (indicated as VC−), in which VC was absent in both growth medium and differentiation medium, and VC-treatment group (indicated as VC+), in which the cells were first cultured for 48 h in growth medium containing 500 μM VC, and then were shifted to differentiated medium containing 500 μM VC. (A) Evaluation of myoblast differentiation in different treatment groups. Cells after 6 d of differentiation induction were immunostained with anti-MyHC antibodies to mark the myotubes. Nuclei were stained with DAPI. Scale bar, 100 μm. (B) Quantification analysis for differentiation efficiency in different treatment groups. The fusion index was calculated as the ratio of the number of nuclei in MyHC- positive cells to the total number of nuclei present in the observation field. (C) qRT-PCR analysis for the expression of myogenin, Myf6 and myomaker in C2C12 cells after 4 d of differentiation induction in different treatment groups. Gapdh was used as an internal control. Data are presented as means ± SEM (n = 3). Asterisks above columns represent significant difference among groups (p < 0.05).

    Article Snippet: To achieve persistent knockdown of Tet2, C2C12 cells was transfected with a Tet2 shRNA plasmid (shTet2) or a control scrambled shRNA plasmid (shCtrl) (Origene Technologies).

    Techniques: Knockdown, Transfection, shRNA, Control, Cell Culture, Staining, Quantitative RT-PCR, Expressing